“White lung syndrome” is not an official medical diagnosis. It’s a colloquial term that gained traction in news headlines, most often referring to pneumonia caused by a bacterium called Mycoplasma pneumoniae. The name comes from how infected lungs look on a chest X-ray: areas that should appear dark (because they’re filled with air) instead show up white, indicating the air spaces have been replaced by fluid, inflammation, or infected tissue.
Why Lungs Appear White on X-Rays
Healthy lungs are mostly air, and air has very low density. On a chest X-ray, that low density shows up as dark space. When something replaces that air, whether it’s fluid, pus, swollen tissue, or mucus, the affected area becomes denser and shows up lighter or white on the image. Radiologists call these bright patches “opacities.”
Lung opacities aren’t unique to any single illness. They can appear with bacterial or viral pneumonia, pulmonary edema (fluid buildup from heart problems), bleeding in the lung tissue, or even cancerous growths. So a “white lung” on an X-ray tells you something is wrong, but not specifically what. The term “white lung syndrome” in recent headlines almost always points to one culprit: Mycoplasma pneumoniae infection, particularly in children.
The Bacterium Behind the Headlines
Mycoplasma pneumoniae is one of the most common causes of bacterial respiratory infections picked up in everyday life, outside of hospitals. It spreads through respiratory droplets and tends to cause what many people know as “walking pneumonia,” a milder form where patients can often keep going about their daily routines rather than ending up bedridden or hospitalized. The bacterium is unusual in that it lacks a cell wall, which makes it naturally resistant to penicillin and related antibiotics.
Most Mycoplasma infections stay mild. But in some cases, especially in young children or people with underlying health conditions, the infection can progress to more significant pneumonia that produces those dramatic white patches on imaging.
The 2024 Surge in Cases
Mycoplasma pneumoniae infections in the United States began rising sharply in April 2024. CDC surveillance data shows just how dramatic the increase was: among hospitalized children 18 and under, Mycoplasma-related pneumonia jumped to 12.5 cases per 1,000 hospitalizations in 2024, compared to an average of just 2.1 per 1,000 during the six preceding years. By July 2024, Mycoplasma accounted for more than half of all pediatric pneumonia hospitalizations, up from a baseline of about 11.5%.
This kind of surge is partly cyclical. Mycoplasma pneumoniae tends to cause outbreaks every few years, and many experts believe the COVID-19 pandemic disrupted normal patterns of exposure and immunity. Children who weren’t exposed to common respiratory pathogens during lockdowns may have been more vulnerable when those pathogens returned.
Symptoms to Recognize
Mycoplasma pneumonia often starts looking like an ordinary cold or upper respiratory infection. The hallmark symptoms include a persistent dry cough, fever, fatigue, chest pain, and loss of appetite. Ear infections sometimes accompany the illness, particularly in children. Many people with mild cases never realize they have pneumonia at all, which is why the “walking pneumonia” nickname stuck.
More serious cases interfere with the lungs’ ability to exchange oxygen and carbon dioxide. When that happens, you’ll notice shortness of breath or visible difficulty breathing. Confusion, a fever lasting more than three or four days, or worsening breathing difficulty are signs the infection may be progressing and needs medical attention.
Who Is Most Vulnerable
Children under six face the highest risk of severe pneumonia in general. Research on hospitalized pediatric pneumonia patients has identified several factors that independently raise the odds of a more dangerous course: congenital heart disease, premature birth, low birth weight, and a previous history of pneumonia. In infants under one year, a history of formula feeding and RSV co-infection also increase risk. For older children between two and five, wheezing on admission is a notable warning sign.
Adults can get Mycoplasma infections too, though severe cases are less common in otherwise healthy adults. People with weakened immune systems or chronic lung conditions face greater risk of complications at any age.
How It’s Treated
Because Mycoplasma bacteria lack a cell wall, standard antibiotics like penicillin and amoxicillin simply don’t work against them. The go-to treatment is a class of antibiotics called macrolides, which includes azithromycin, the familiar “Z-pack.” Most patients improve within a few days of starting treatment.
A small but notable percentage of Mycoplasma strains have developed resistance to macrolides. Globally, resistance rates vary widely, but in the United States they’ve stayed under 10%. When a patient doesn’t improve on first-line treatment, doctors can switch to alternative antibiotic classes. Mild cases of walking pneumonia sometimes resolve on their own without antibiotics, though treatment can shorten the illness and reduce the chance of spreading it.
Prevention
There is no vaccine specifically targeting Mycoplasma pneumoniae. Prevention relies on the same measures that limit any respiratory infection: regular handwashing, covering coughs and sneezes, and keeping sick children home from school or daycare.
Vaccines do exist for other bacteria that cause pneumonia in children, most notably the pneumococcal conjugate vaccine (PCV), which protects against Streptococcus pneumoniae. Countries that have introduced this vaccine into routine childhood immunization schedules have seen meaningful declines in pneumonia hospitalization rates among young children. While it won’t prevent Mycoplasma infections, it reduces the overall burden of pneumonia and the chance of bacterial co-infections that can make illness worse.
White Lung Syndrome vs. ARDS
Some people confuse “white lung syndrome” with acute respiratory distress syndrome, or ARDS, a life-threatening condition that also produces widespread white-out on chest X-rays. ARDS is a medical emergency where the lungs become severely inflamed and fill with fluid, making it extremely difficult to breathe. It can be triggered by severe pneumonia of any kind, sepsis, trauma, or inhalation injuries. Patients with ARDS typically need intensive care and mechanical ventilation.
The Mycoplasma pneumonia behind most “white lung syndrome” headlines is far less severe. While the X-ray findings can look alarming, the vast majority of patients recover fully with appropriate antibiotics or even without treatment. ARDS remains rare, even during surges in respiratory infections. The overlap in how the lungs look on imaging is real, but the two conditions sit at very different points on the severity spectrum.